147 related articles for article (PubMed ID: 2568685)
1. [A new beta 1-receptor blocker in the therapy of essential hypertension and angina pectoris].
Burkart F; Stamm G; Witassek F
Schweiz Med Wochenschr; 1989 May; 119(18):575-81. PubMed ID: 2568685
[TBL] [Abstract][Full Text] [Related]
2. Bisoprolol--another cardioselective beta blocker.
Drug Ther Bull; 1989 Jul; 27(14):55-6. PubMed ID: 2577508
[No Abstract] [Full Text] [Related]
3. Age dependence of therapy result and risk in the treatment of arterial hypertension?
Höffler D; Morgenstern HO
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
[TBL] [Abstract][Full Text] [Related]
4. Bisoprolol in the treatment of chronic stable angina pectoris.
Terol I; Plaza L; Rodrigo F
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S208-12. PubMed ID: 11527131
[TBL] [Abstract][Full Text] [Related]
5. [New specialty drugs registered in Austria. Concor].
Graffius D
Wien Klin Wochenschr; 1990 Mar; 102(6):180-4. PubMed ID: 1970446
[No Abstract] [Full Text] [Related]
6. Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respiration.
Szám I; Büky P; Gulyás A; Sinkovics M
Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):128-33. PubMed ID: 6121761
[TBL] [Abstract][Full Text] [Related]
7. Long-term treatment of angina pectoris with bisoprolol or atenolol in patients with chronic obstructive bronchitis: a randomized, double-blind crossover study.
Dorow P; Thalhofer S; Bethge H; Disselhoff G; Wagner G
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S36-44. PubMed ID: 11527135
[TBL] [Abstract][Full Text] [Related]
8. [Acute changes of coronary and global hemodynamics in patients with angina pectoris and arterial hypertension caused by celiprolol and metoprolol].
Franz N; Modersohn D; Linss G; Heublein B; Gola G; Bruch L; Walde T
Radiol Diagn (Berl); 1990; 31(6):625-8. PubMed ID: 1982742
[TBL] [Abstract][Full Text] [Related]
9. Incidence of side effects during the application of placebo and active therapy (Tobanum) in patients suffering from hypertension, angina pectoris and arrhythmia.
Török E; Kósa E; Szontagh M; Juvancz P; Eggenhofer J; Borvendég J
Int J Clin Pharmacol Ther Toxicol; 1985 Dec; 23(12):650-6. PubMed ID: 2868999
[TBL] [Abstract][Full Text] [Related]
10. [Long-term studies on the beta blocker talinolol (cordanum) with special reference to side effects].
Mann D; Boguschewski KD; Brämer U; Dobritz H; Hitzeroth T
Z Gesamte Inn Med; 1979 Apr; 34(7):192-5. PubMed ID: 39387
[TBL] [Abstract][Full Text] [Related]
11. [Longterm therapy of angina pectoris patients with a new beta-receptor blocker (author's transl)].
Schaumann HJ; Diekmann HJ; Neuss H; Stegaru B
MMW Munch Med Wochenschr; 1976 Sep; 118(36):1123-5. PubMed ID: 9583
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study of the action of a series of new beta-adrenergic receptor blockaders in patients with effort angina].
Romakov AIu; Sagirov AM; Desiatnichenko VM; Sobol' IuS; Sumarokov AB
Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1983; 6(2):57-63. PubMed ID: 6139118
[TBL] [Abstract][Full Text] [Related]
13. Hemodynamics and exercise tolerance after bisoprolol, nifedipine, and their combination in patients with angina pectoris.
Schnellbacher K; Bestehorn HP; Roskamm H
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S201-7. PubMed ID: 11527130
[TBL] [Abstract][Full Text] [Related]
14. [Effects of beta 1-adrenoblocker bisoprolol on endothelial dysfunction in patients with stable angina pectoris in combination with chronic obstructive pulmonary disease].
Grigor'eva NIu; Sharabrin EG; Kuznetsov AN; Mazalov KV; Kontorshchikova KN; Koroleva EF
Ter Arkh; 2009; 81(3):28-31. PubMed ID: 19459418
[TBL] [Abstract][Full Text] [Related]
15. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
Hill LS; Fand RS
Ir Med J; 1979 Dec; 72(12):522-9. PubMed ID: 44273
[No Abstract] [Full Text] [Related]
16. Safety and efficacy of beta-blockers in the treatment of stable angina pectoris.
de Muinck ED; Lie KI
J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S123-8. PubMed ID: 11527115
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of migraine using bisoprolol. Results of a double-blind study versus metoprolol].
Wörz R; Reinhardt-Benmalek B; Föh M; Grotemeyer KH; Scharafinski HW
Fortschr Med; 1992 May; 110(14):268-72. PubMed ID: 1351025
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
[TBL] [Abstract][Full Text] [Related]
19. Response of blood pressure, cardiac output, peripheral resistance, and exercise performance to substitution of calcium blocker for beta-blocker plus thiazide diuretic therapy in patients with both systemic hypertension and mild stable angina.
Kawanishi DT; Reid CL; Gonzales A; O'Rourke RA; Rahimtoola SH
Circulation; 1989 Dec; 80(6 Suppl):IV162-70. PubMed ID: 2574640
[TBL] [Abstract][Full Text] [Related]
20. Nadolol (Corgard) - a new beta-blocker.
Med Lett Drugs Ther; 1980 Apr; 22(8):33-4. PubMed ID: 6102734
[No Abstract] [Full Text] [Related]
[Next] [New Search]
